Gartner, Inc. Remaining Share Repurchase Authorization
Gartner, Inc. (IT) had Remaining Share Repurchase Authorization of $800.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2026-08-04
- 2026-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $800.00M.
- 2026-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $700.00M.
- 2025-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $700.00M.
- 2025-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.30B.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2026-06-30 | $800.00M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $700.00M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $700.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $1.30B 10-Q · filed 2025-11-04 |
| 2025-06-30 | $600.00M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $900.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $953.80M 10-K · filed 2025-02-13 |
| 2024-09-30 | $1.00B 10-Q · filed 2024-11-05 |
| 2024-06-30 | $487.80M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $831.30M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $987.00M 10-K · filed 2024-02-15 |
| 2023-09-30 | $610.80M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $827.90M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $954.50M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $606.00M 10-K · filed 2023-02-16 |
| 2022-09-30 | $612.80M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $704.40M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $677.80M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $591.00M 10-K · filed 2022-02-23 |
| 2021-09-30 | $776.30M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $300.00M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $500.00M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $600.00M 10-K · filed 2021-02-24 |
| 2020-09-30 | $700.00M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $700.00M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $700.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $700.00M 10-K · filed 2020-02-19 |
| 2019-09-30 | $800.00M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $900.00M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $900.00M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $900.00M 10-K · filed 2019-02-22 |
| 2018-09-30 | $1.00B 10-Q · filed 2018-11-01 |
| 2018-06-30 | $1.00B 10-Q · filed 2018-08-01 |
| 2018-03-31 | $1.10B 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.10B 10-K · filed 2018-02-22 |
| 2017-09-30 | $1.10B 10-Q · filed 2017-11-02 |
| 2017-06-30 | $1.10B 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.10B 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.10B 10-K · filed 2017-02-22 |
| 2016-09-30 | $1.11B 10-Q · filed 2016-11-03 |
| 2015-12-31 | $1.10B 10-K · filed 2016-02-24 |
| 2014-12-31 | $413.30M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |